While some new medications have helped advance the treatment of hypertrophic cardiomyopathy, experts say improvements in ...

"This technology will allow us to get the right drug, to the right person, at the right time," says Maynes, Chief of the Department of Anesthesia and Pain Medicine, Associate Chief of Research for ...

A new clinical practice guideline provides updated recommendations for the treatment of restless legs syndrome. The guideline reflects the latest scientific evidence and recommends significant changes ...

an investigational RNAi therapeutic in development for the treatment of ATTR amyloidosis with cardiomyopathy (ATTR-CM). Vutrisiran is the generic name for AMVUTTRA ®, which is currently approved ...

Hypertrophic cardiomyopathy (HCM ... and the most appropriate investigations for persons suspected of having HCM. Treatment strategies for the disease and its complications are presented briefly.

focusing on DMD-cardiomyopathy to expedite the approval process. This decision aligns with the unmet clinical need and strong demand for new treatments in the field. Additionally, he notes ...

HCM is a relatively common genetic cardiomyopathy that can be a challenge to diagnose, with about one in three patients misdiagnosed as having another cardiomyopathy. Genetic testing identifies a ...

We look forward to working closely with the EMA with the aim to bring this new treatment option to patients ... test), quality of life (Kansas City Cardiomyopathy Questionnaire), and heart failure ...

Background: Symptoms are among the most important factors impacting quality of life (QOL) in hypertrophic cardiomyopathy (HCM) patients, and reflect a poor prognosis. Whether emotional stress can ...

An advanced robotic system at The Hospital for Sick Children (SickKids) is changing the way physicians and scientists ...